Fever Clinical Trial
Official title:
Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever
Currently, when a child has fever either ibuprofen (e.g. Motrin, Advil) or acetaminophen (e.g. Tylenol) is given. Both Ibuprofen and Acetaminophen are approved for over the counter use for treatment of fever by the Food and Drug Administration (FDA). This study hopes to determine whether giving both medications together is better than giving one medication alone for the treatment of fever.
Despite a lack of evidence to support their fears, a majority of parents, pediatricians, and
pediatric nurses believe that fever can be dangerous to a child. This "fever phobia" has
caused a majority of caregivers to aggressively treat fever with antipyretics such as
ibuprofen and acetaminophen, often in combination. Although there is scant data to support
the use of these medications together for fever control and none using alternating regimens,
it was recently reported that 50% of pediatricians and 70% of pediatricians with less than 5
years of experience advise parents to alternate acetaminophen and ibuprofen as an attempt to
achieve maximal antipyresis. While a combination of aspirin (no longer used for antipyresis
in children) and acetaminophen has been shown to be superior to either agent alone for fever
reduction, these data cannot be extrapolated to the pairing of ibuprofen and acetaminophen.
There is evidence that combinations of acetaminophen and non-steroidal anti-inflammatory
drugs (NSAIDs) are more effective for the treatment of pain and can reduce opioid use when
compared with a single agent. Improved activity and alertness in children have been reported
after antipyretic administration.
It is believed that acetaminophen and ibuprofen may be safely used together because the two
medications have significantly different pathways of metabolism that are not affected by
each other, and have been used abroad in combination form for over a decade. Both
acetaminophen and ibuprofen have been shown to be safe when given individually or together
in recommended doses for short term use. There are no reports of adverse effects from
combination therapy with standard doses.
In addition, while it now appears that fever itself is probably a protective physiologic
response, under different circumstances it has the potential to be harmful. Fever increases
the metabolic rate approximately 10% for every 1 degree C rise in body temperature. The
myocardial depression,orthostatic dysfunction, and increases in oxygen consumption,
respiratory minute volume, and respiratory quotient that occur may not be tolerated by all
patients including some children.
Because of the ubiquitous nature of the problem, childhood fever, this study has the
potential to immediately impact the way clinicians and parents treat children with fever. If
the combination regimens are not shown to be superior, it could limit improper medication
administration and overdose. If it is superior, the combination of medications may improve
other symptoms associated with fever such as discomfort. Either way, it will fill the gap
that exists in the evidence-based approach to the management of childhood fever and
immediately impact current practice.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
| Completed |
NCT03706599 -
Fever Infants and Therapeutic Education in Emergency Department
|
N/A | |
| Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
| Not yet recruiting |
NCT01782183 -
Thermographic Characteristics of Sore Throat by Thermographic Camera
|
N/A | |
| Withdrawn |
NCT00800696 -
Preventive Oral Care
|
N/A | |
| Completed |
NCT02212990 -
The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine
|
N/A | |
| Completed |
NCT02689193 -
IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres
|
||
| Completed |
NCT01911143 -
A Retrospective, Blinded Validation of a Host-response Based Diagnostics
|
N/A | |
| Completed |
NCT01869699 -
Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults
|
Phase 4 | |
| Completed |
NCT01194557 -
Introducing Rapid Diagnostic Tests Into the Private Health Sector
|
N/A | |
| Completed |
NCT01559675 -
Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery
|
N/A | |
| Completed |
NCT00969176 -
Pharmacokinetics, -Dynamics and Safety of Intravenous Paracetamol in Neonates
|
Phase 2/Phase 3 | |
| Completed |
NCT00940654 -
The Fever and Antipyretic in Critically Illness Evaluation Study
|
N/A | |
| Recruiting |
NCT00729976 -
Oral Versus Rectal Ibuprofen for Fever in Young Children - a Randomized Control Study.
|
Phase 4 | |
| Recruiting |
NCT00389272 -
Adding a Second Drug for Febrile Children Treated With Acetaminophen
|
N/A | |
| Completed |
NCT00257790 -
The Tobramycin Study
|
Phase 4 | |
| Recruiting |
NCT05033613 -
Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease
|
||
| Completed |
NCT02595827 -
Non-inferiority Trial of Conditional vs Universal Follow up for Children With Fever in Democratic Republic of Congo
|
Phase 3 | |
| Recruiting |
NCT06061575 -
Comparison of the Efficacy of Paracetamol and Ibuprofen in the Management of Fever in Sepsis Patients
|
Phase 4 | |
| Recruiting |
NCT06038617 -
Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children
|
Phase 4 |